輸血デバイス市場- 世界の産業規模、シェア、動向、機会、予測：製品別、最終用途別、地域別セグメント、競合、2020年～2030年

輸血デバイスの世界市場は、2024年に48億米ドルと評価され、2030年には66億1,000万米ドルに達し、CAGR 5.68%で成長すると予測されています。

血液バッグ、輸血フィルター、輸液ポンプ、アフェレシスシステムを含む輸血デバイスは、血液成分の安全かつ効率的な収集、処理、投与を保証するために不可欠です。貧血、がん、血友病、腎臓病など、輸血を繰り返し必要とする病態の有病率の増加は、市場成長を促進する重要な要因です。

さらに、特にヘルスケアシステムが拡大している発展途上国において、外傷や産科合併症を含む緊急症例の増加が引き続き需要を牽引しています。財政的・物流的課題は残るもの、技術の進歩、ヘルスケア支出の増加、輸血業務の安全性と効率性への注目の高まりにより、市場の見通しは明るいです。先進国市場と新興国市場の両方でヘルスケア・インフラが強化されるにつれて、高度な輸血技術の統合が加速するものと思われます。

主な市場促進要因

ヘルスケア産業の成長

主な市場課題

高い資本コストと運用コスト

主な市場動向

分散型採血モデルの拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界の輸血デバイス市場に与える影響

第5章 世界の輸血デバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（成分分析システム、輸液装置、血液加温器、静脈アクセス装置、フィルター、その他）
  • 用途別（病院、外来手術センター、透析センター、血液銀行、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の輸血デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の輸血デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の輸血デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の輸血デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの輸血デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 世界の輸血デバイス市場：SWOT分析

第15章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第16章 競合情勢

• Immucor Inc.
• Becton Dickinson and Company
• B. Braun Melsungen AG
• Terumo Corporation
• Grifols SA
• Kaneka Corporation
• Fresenius Kabi AG
• Haemonetics Corporation
• Macopharma SA
• Ecomed Solutions, LLC.

第17章 戦略的提言

第18章 調査会社について・免責事項

The Global Blood Transfusion Devices Market was valued at USD 4.80 Billion in 2024 and is projected to reach USD 6.61 Billion by 2030, growing at a CAGR of 5.68%. Blood transfusion devices, which include blood bags, transfusion filters, infusion pumps, and apheresis systems, are vital for ensuring the safe and efficient collection, processing, and administration of blood components. The increasing prevalence of medical conditions such as anemia, cancer, hemophilia, and kidney disease-which often necessitate recurrent transfusions-is a key factor propelling market growth.

Additionally, the rise in emergency cases, including trauma and obstetric complications, particularly in developing nations with expanding healthcare systems, continues to drive demand. While financial and logistical challenges remain, the market outlook is positive due to technological advancements, increased healthcare spending, and heightened focus on safety and efficiency in transfusion practices. As both developed and emerging markets enhance their healthcare infrastructure, the integration of advanced transfusion technologies is set to accelerate.

Key Market Drivers

Growth in Healthcare Industry

The expanding global healthcare industry is a key driver supporting the growth of the blood transfusion devices market. Generating over USD 4 trillion annually, the healthcare sector includes pharmaceuticals, biotechnology, medical technology, and diagnostics-each playing a pivotal role in supporting transfusion needs.

Rising rates of surgical procedures, organ transplants, cancer treatments, and emergency interventions require reliable access to blood components like red cells, platelets, and plasma. However, disparities remain-only 6% of the 313 million global procedures occur in the poorest regions, despite these areas housing over a third of the global population. This imbalance results in higher fatality rates for treatable conditions. With more hospitals and clinics being established, especially in underserved regions, demand for transfusion equipment continues to rise, driven by both clinical need and improvements in infrastructure.

Key Market Challenges

High Capital and Operational Costs

The significant costs associated with blood transfusion equipment remain a major challenge for market expansion. Advanced technologies have improved the quality and safety of transfusion procedures but have also raised the financial barriers for adoption.

Establishing modern transfusion facilities requires substantial investment in equipment such as apheresis machines, automated processing systems, and temperature-controlled storage units. In low- and middle-income countries, these upfront and ongoing operational costs often hinder adoption, limiting the reach of quality transfusion care. Budget constraints among healthcare providers further exacerbate disparities in access, affecting both availability and patient outcomes.

Key Market Trends

Expansion of Decentralized Blood Collection Models

An important trend shaping the blood transfusion devices market is the transition toward decentralized collection models. To improve the resilience and reach of blood supply systems, healthcare systems are increasingly deploying mobile collection units, community-based sites, and rural health posts in addition to central facilities.

Innovations such as Touch Activated Phlebotomy (TAP) devices are enhancing the convenience and safety of decentralized blood collection by enabling painless, reliable, and self-administered capillary blood draws-without the need for trained phlebotomists. These models offer scalable, flexible solutions for broader population coverage, especially in hard-to-reach areas.

Key Market Players

• Immucor Inc.
• Becton Dickinson and Company
• B. Braun Melsungen AG
• Terumo Corporation
• Grifols SA
• Kaneka Corporation
• Fresenius Kabi AG
• Haemonetics Corporation
• Macopharma SA
• Ecomed Solutions, LLC.

Report Scope

In this report, the Global Blood Transfusion Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Transfusion Devices Market, By Product:

• Apheresis Systems
• Infusion Devices
• Blood Warmers
• Venous Access Devices
• Filters
• Others

Blood Transfusion Devices Market, By End Use:

• Hospital
• Ambulatory Surgical Centers
• Dialysis Centers
• Blood Bank
• Others

Blood Transfusion Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Transfusion Devices Market.

Available Customizations

Global Blood Transfusion Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Blood Transfusion Devices Market

5. Global Blood Transfusion Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)
  • 5.2.2. By End Use (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Blood Transfusion Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Transfusion Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End Use
  • 6.3.2. Mexico Blood Transfusion Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End Use
  • 6.3.3. Canada Blood Transfusion Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End Use

7. Europe Blood Transfusion Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Blood Transfusion Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End Use
  • 7.3.2. Germany Blood Transfusion Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Blood Transfusion Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Blood Transfusion Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Blood Transfusion Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End Use

8. Asia Pacific Blood Transfusion Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Transfusion Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Blood Transfusion Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End Use
  • 8.3.3. South Korea Blood Transfusion Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End Use
  • 8.3.4. Japan Blood Transfusion Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Blood Transfusion Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End Use

9. South America Blood Transfusion Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Blood Transfusion Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Blood Transfusion Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Blood Transfusion Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Blood Transfusion Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Blood Transfusion Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Blood Transfusion Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Blood Transfusion Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Blood Transfusion Devices Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Immucor Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Becton Dickinson and Company
• 16.3. B. Braun Melsungen AG
• 16.4. Terumo Corporation
• 16.5. Grifols SA
• 16.6. Kaneka Corporation
• 16.7. Fresenius Kabi AG
• 16.8. Haemonetics Corporation
• 16.9. Macopharma SA
• 16.10. Ecomed Solutions, LLC.

17. Strategic Recommendations

18. About Us & Disclaimer